Yesterday I covered a link between apparently “independent” Director at Edge Performance VCT (EDGI and EDGH) Sir Peter Bazalgette and its lead fund manager Mr David Glick at Edge Creative Enterprise Fund. Today I turn to a company called Mirriad Limited, a company in which Edge Performance VCT saw a £3.3 million investment written down by 98 to just £50,000 in 2015. It was the biggest cause of Edge’s loss that year.
In my article of 22 July, I revealed the piss poor CV of David Bull, the new Non-Executive Director for Supply@ME Capital (SYME). In the career summary issued via the RNS, he managed to omit key facts such as his close links to outgoing Chairman Dominic White (in his capacity as a Non-Executive Director of Dominic White’s Eight Capital Partners Plc) and his prior role as CFO of now suspended AIM share PCF Group Plc (PCF) caused by a number of deficiencies in PCF’s financial control and reporting function.
It was announced today that Chairman of Golden Prospect, Malcolm Burne, has opened his wallet and bought 25,000 more shares at 50p a pop. Now sometimes boardroom buying is just a spoof and the amount inconsequential, but I would suggest readers take this director purchase a little more seriously.
I see that NED Robin Fryer at AIM-listed Shanta Gold (SHG) has dumped his entire holding of the company’s stock. And CEO of Ariana Resources has been cashing in on options – and selling. Should we read either as a cue to follow suit and sell?
To be fair to ShareProphets AIM-China Filthy Forty play Walcom (WALG) it has made no secret of its financial woes since its formerly best customer defaulted on payments owed, plunging the company into crisis, even if the initial announcements suggested mis-placed confidence that the default would be resolved.
AIM-listed Advanced Oncotherapy (AVO) announced director and significant shareholdings this morning, following its latest fundraising in December and resulting share issues yesterday. But it seems that one of the directors has been – undisclosed – selling!
AIM-listed Ariana Resources (AAU) announced a series of director share purchases which, as promised, mops up most of the share buy-back shambles earlier this week. This is good: the shares are in strong hands and shows that the directors have faith. It also shows that they are doing their best to make amends out of their own pockets.
AIM-listed Tern (TERN) has announced that two of its directors have been purchasing shares. Normally one would pay attention, but there are good reasons to see through this as just a spoof.
A little bird emailed me with some interesting questions about AIM-listed React Group (REAT) and its new(ish) FD. In the light of the HotStockRockets update at the weekend (see HERE), where questions over the management’s ability to get their sums right were asked in the wake of a revised (downwards) trading statement, it seems that the FD has a few questions to answer – and I have some more.
It’s not much to ask for any AIM-listed company to get its Companies House filings right, and consistent with its RNSs, is it? But then AIM-listed Tern plc (TERN) has had a few issues with this in the past. So, Tern, when did Richard Turner join the board?
Phew! 153 company directorships to plough through from the career of AIM-listed Advanced Oncotherapy’s Executive Chairman. He sure has been a busy chap. Actually the number is dropping slightly as a few more double entries come up on the OpenCorporates.com website – just as well. Having looked through the first 30 entries on Sunday (29 after sifting out double entries) and the same again yesterday, we come to the next 30 from our search of the career of Dr Michael Jeffrey Sinclair.
Hello Share Pushers. Barclays Bank is one of those shares I’ve held for years and years and rather wish I didn’t. No sooner do I top up then another bombshell, usually to do with world economics, hits - and down the shares come again. Were it not for the divi, I might have gone round and lambasted a director or two.
A chance encounter with a London lawyer whilst on holiday has drawn my attention to the issue of the useless regulation of London’s AIM market and how market forces may find a way to address the shortcomings so often bemoaned here on ShareProphets.
Well, well – another twist in the formerly AIM-listed Teathers (TEA) saga has emerged, as a wander through Companies House filings reveals that a certain Mr Jason Drummond quit as a director on 23 June 2016 (last Thursday), ahead of the forthcoming sack-the-board EGM on Tuesday. The question, of course, is why?
AIM-listed Shanta Gold (SHG) has announced another director share purchase which looks to me to be more of a sell signal than a buy signal. I previously highlighted (HERE) that CEO Toby Bradbury had changed his mind about supporting the recent fundraising by ponying up for 500,000 shares at the offer price of 6.5p – instead completing half of promised purchase in the market at the reduced price of 5.65p. Today we learn that NED Robin Fryer has put his hand in his pocket to the tune of 45,000 shares at 6.2p.
It looks like Rob Terry and the old Quindell (QPP) gang are getting back together with news that Stephen Scott has been appointed as a director of Quob Park Estates. Of course, this being a Rob Terry vehicle there are one or two problems with the manner of disclosure...
Oh please. I am still laughing. You could not make this up. Well you could. Circle Oil (COP) has today appointed a new director Dr Keith Morris. Yes the name rings a bell. This is a scream.